Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Abcam plc

ABCMNASDAQ
Healthcare
Biotechnology
$23.99
$0.010(0.04%)
U.S. Market is Open • 12:29

Abcam plc Fundamental Analysis

Abcam plc (ABCM) shows weak financial fundamentals with a PE ratio of -478.66, profit margin of -2.35%, and ROE of -1.23%. The company generates $0.4B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-6.45

Areas of Concern

ROE-1.23%
Operating Margin-2.82%
Cash Position1.62%
We analyze ABCM's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 25.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
25.2/100

We analyze ABCM's fundamental strength across five key dimensions:

Efficiency Score

Weak

ABCM struggles to generate sufficient returns from assets.

ROA > 10%
-0.80%

Valuation Score

Excellent

ABCM trades at attractive valuation levels.

PE < 25
-478.66
PEG Ratio < 2
-6.45

Growth Score

Moderate

ABCM shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

ABCM maintains a strong and stable balance sheet.

Debt/Equity < 1
0.31
Current Ratio > 1
1.27

Profitability Score

Weak

ABCM struggles to sustain strong margins.

ROE > 15%
-122.92%
Net Margin ≥ 15%
-2.35%
Positive Free Cash Flow
No

Key Financial Metrics

Is ABCM Expensive or Cheap?

P/E Ratio

ABCM trades at -478.66 times earnings. This suggests potential undervaluation.

-478.66

PEG Ratio

When adjusting for growth, ABCM's PEG of -6.45 indicates potential undervaluation.

-6.45

Price to Book

The market values Abcam plc at 5.60 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

5.60

EV/EBITDA

Enterprise value stands at 92.73 times EBITDA. This signals the market has high growth expectations.

92.73

How Well Does ABCM Make Money?

Net Profit Margin

For every $100 in sales, Abcam plc keeps $-2.35 as profit after all expenses.

-2.35%

Operating Margin

Core operations generate -2.82 in profit for every $100 in revenue, before interest and taxes.

-2.82%

ROE

Management delivers $-1.23 in profit for every $100 of shareholder equity.

-1.23%

ROA

Abcam plc generates $-0.80 in profit for every $100 in assets, demonstrating efficient asset deployment.

-0.80%

Following the Money - Real Cash Generation

Operating Cash Flow

Abcam plc generates limited operating cash flow of $28.88M, signaling weaker underlying cash strength.

$28.88M

Free Cash Flow

Abcam plc generates weak or negative free cash flow of $-12.68M, restricting financial flexibility.

$-12.68M

FCF Per Share

Each share generates $-0.06 in free cash annually.

$-0.06

FCF Yield

ABCM converts -0.31% of its market value into free cash.

-0.31%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-478.66

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-6.45

vs 25 benchmark

P/B Ratio

Price to book value ratio

5.60

vs 25 benchmark

P/S Ratio

Price to sales ratio

11.32

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.31

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.27

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.01

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

-0.01

vs 25 benchmark

How ABCM Stacks Against Its Sector Peers

MetricABCM ValueSector AveragePerformance
P/E Ratio-478.6629.43 Better (Cheaper)
ROE-1.23%800.00% Weak
Net Margin-2.35%-20145.00% (disorted) Weak
Debt/Equity0.310.30 Neutral
Current Ratio1.274.64 Neutral
ROA-0.80%-17936.00% (disorted) Weak

ABCM outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Abcam plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ